After being awarded a $5.1 million fee from More Pharma one month ago, shares of Microcyn® technology developer Oculus Innovative Sciences, Inc. (OCLS) should see another pop in it’s penny stock today now that they actually received it. Gaining as much as 35.14% since our initial alert three months ...
Continue Reading →SEP